NEW YORK (GenomeWeb News) – In Nature Genetics, members of the International Headache Genetics Consortium reported on a dozen apparent risk loci for migraine headaches, including five not described in the past.

The team tracked down the migraine-associated sites through a meta-analysis of data from dozens of past genome-wide association studies involving nearly 23,300 migraine sufferers and more than 95,400 unaffected individuals from the same populations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.